Piribedil for symptomatic management of Parkinson's disease

To evaluate the effectiveness and safety of piribedil for the symptomatic treatment of Parkinson's disease in monotherapy or adjuvant to levodopa.

This is a protocol.

Health topics:

Neurology > Movement disorders > Parkinson's disease

Published:

21 January 2009

Authors:

Neutel D, Ferreira J, Coelho MM, Rosa MM, Rascol O, Sampaio C

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Neutel D, Ferreira J, Coelho MM, Rosa MM, Rascol O, Sampaio C. Piribedil for symptomatic management of Parkinson's disease. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006708. DOI: 10.1002/14651858.CD006708